Philip Morris vs. British American Tobacco: Which Tobacco Giant Wins for Income Investors?

Philip Morris International (NYSE: PM | PM Price Prediction) and British American Tobacco (NYSE: BTI) both just reported full-year 2025 results, and for income investors choosing between them, the contrast is sharper than it looks. One is executing a textbook transformation into smoke-free products. The other is cheaper, yields more, and just raised its dividend meaningfully.

PM’s Smoke-Free Engine Runs Hot. BTI Keeps the Lights On.

Philip Morris had a strong 2025. Full-year revenue hit $40.6 billion, with the smoke-free segment accounting for close to $17 billion of that total. IQOS continues to dominate its category, holding roughly 76% of global heated tobacco unit volume share. ZYN shipped 794 million cans in the U.S. alone for the full year, growing 37%.

CEO Jacek Olczak on the earnings call: “We achieved another remarkable year of results in 2025, with a fifth consecutive year of volume growth, net revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and very good operating margin expansion.”

That margin story matters. Adjusted operating income margin expanded to 40.4%, and management is guiding for adjusted diluted EPS of $8.38 to $8.53 in 2026, implying roughly 11% to 13% growth.

BTI’s picture is less dynamic but not without appeal. The company reported Q4 2025 EPS of $2.55, beating the $2.51 estimate. Brands like Vuse, Velo, and glo anchor its next-generation portfolio, though growth lags PM’s smoke-free momentum. What BTI lacks in transformation narrative, it partially compensates for in valuation and yield.

Yield vs. Growth: Two Very Different Income Propositions

BTI’s 2026 quarterly dividend of $0.835 is a meaningful step up from 2025’s $0.749. At forward P/E of roughly 12x, BTI trades at a significant discount to PM’s 20x forward multiple. That gap is the whole debate.

Why the Valuation Gap Is the Real Question

PM commands a premium because it has earned one. Eleven of the last twelve quarters saw earnings beats. The smoke-free business is growing gross profit faster than revenue. The risk is that you are paying a growth-stock multiple for a tobacco company, and any stumble in ZYN volumes or IQOS market share could compress that multiple quickly.

BTI at 13x trailing earnings looks cheap, but the earnings history is noisy. A -$0.66 EPS print in Q4 2024 and a significant miss in Q2 2025 ($2.04 vs. $2.24 estimated) raise questions about earnings consistency that PM simply does not have.

PM for Compounders, BTI for Pure Yield Seekers

Investors focused purely on yield will note BTI’s higher payout and lower valuation — characteristics historically associated with mature cash flow businesses trading at a discount. Those prioritizing dividend growth alongside capital appreciation may weigh PM’s smoke-free transformation, consistent earnings beats, and decade-plus dividend growth record differently. The valuation gap between the two reflects those differing profiles.